We propose that FAPI-PET may offer a solution to this problem, as it comprehensively identifies FAP-rich stroma (and thereby ‘CMS4 load’) in all target lesions, without the need to infer subtype from histological analysis of the primary tumour, and without the need for additional invasive biopsy procedures. Here, FAP is linked to neoplasm.